Side Effects & Safety Nausea 44% in STEP trials, most common side effect, dose-dependent Diarrhea 30% in trials Vomiting 24% in trials Constipation 24% in trials Stomach pain 20% in trials Pancreatitis rare but documented
It was also an early observation that a higher dose of GLP-1 is needed to produce satiety and reduced food intake than to the antidiabetic effect, so a low dose GLP-1 analog could be used to study weight loss independent effects of GLP-1
Firstly, three reviewers (HY, AZ, and J-YW) independently selected the articles according to the title, and any uncertain entries were included
Unlike insulin or other non discretionary drugs, there is a wide gap between the eligible population and the number of people actually on therapy
The interaction between semaglutide and the ketogenic diet holds potential for individuals looking to enhance weight loss and improve glycemic control
Honesty requires acknowledging this alongside the limitations